Corteva, Inc. $CTVA Shares Sold by Inceptionr LLC

Inceptionr LLC trimmed its stake in Corteva, Inc. (NYSE:CTVA) by 72.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,243 shares of the company’s stock after selling 16,026 shares during the period. Inceptionr LLC’s holdings in Corteva were worth $422,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Private Advisor Group LLC grew its holdings in shares of Corteva by 4.1% during the third quarter. Private Advisor Group LLC now owns 31,692 shares of the company’s stock worth $2,143,000 after purchasing an additional 1,261 shares during the last quarter. Jefferies Financial Group Inc. lifted its holdings in shares of Corteva by 96.7% in the 3rd quarter. Jefferies Financial Group Inc. now owns 20,779 shares of the company’s stock valued at $1,405,000 after purchasing an additional 10,213 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Corteva in the 3rd quarter valued at about $305,000. Parallel Advisors LLC grew its stake in Corteva by 1.1% during the 3rd quarter. Parallel Advisors LLC now owns 35,683 shares of the company’s stock worth $2,413,000 after buying an additional 383 shares during the last quarter. Finally, Meiji Yasuda Life Insurance Co grew its stake in Corteva by 22.2% during the 3rd quarter. Meiji Yasuda Life Insurance Co now owns 26,425 shares of the company’s stock worth $1,787,000 after buying an additional 4,797 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Trading Up 3.1%

Shares of CTVA stock opened at $78.65 on Thursday. The business’s 50 day moving average is $73.63 and its two-hundred day moving average is $69.13. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $80.90. The company has a market capitalization of $52.89 billion, a P/E ratio of 49.78, a price-to-earnings-growth ratio of 2.61 and a beta of 0.72. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the company posted $0.32 earnings per share. The company’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.14% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CTVA. Weiss Ratings reiterated a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Royal Bank Of Canada lifted their target price on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Citigroup upped their price target on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Finally, CICC Research raised their price objective on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 11th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $82.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.